[KROS] QoQ Quarter Result on 31-Mar-2022 [#Q1]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
05-May-2022
Financial Year
2022
Quarter
31-Mar-2022 [#Q1]
Profit Trend
QoQ- -248.52%
YoY- -52.26%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 0 0 100 0 20,000 0 100 -
PBT -29,718 -23,509 -27,266 -24,186 -4,942 -20,335 -15,622 53.34%
Tax 2 -4,467 -3,462 1 1,998 -38 -79 -
NP -29,720 -19,042 -23,804 -24,187 -6,940 -20,297 -15,622 53.35%
Tax Rate - - - - - - - -
Total Cost 29,720 19,042 23,904 24,187 26,940 20,297 15,722 52.70%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 0.00 0.00 -23,804.00 0.00 -34.70 0.00 -15,622.00 -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
EPS -1.09 -0.75 -0.99 -1.01 -0.30 -0.87 -0.67 38.20%
EPS Diluted -1.09 -0.75 -0.99 -1.01 -0.30 -0.87 -0.67 38.20%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.